Skip to content

Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material

The Effect of Two Different Contemporary Chelating Agents on Vital Pulp Therapy in Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05970536
Enrollment
40
Registered
2023-08-01
Start date
2022-12-01
Completion date
2023-12-01
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vital Pulp Therapy

Brief summary

This clinical trial is designed to study and compare the effect of two different types of chelating agents on the vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.

Detailed description

1. The vital pulps exposed by caries process is treated by complete caries removal followed by full pulpotomy. 2. After hemostasis, application of apple vinegar and EDTA 17% will be used followed by MTA application. finally teeth will be restored with resin composite restoration.

Interventions

OTHERApple vinegar or EDTA 17%

Application of each chelating agent for 5 minutes for dentin conditioning followed by placement of MTA on the pulp chamber.

Sponsors

Sinai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

double ( participant, outcome assessor)

Intervention model description

Parallel double blinded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Presence of at least one tooth with carious pulp exposure and irreversible pulpitis. * Cooperative behavior with no medical problem. * Absence of tooth mobility , tenderness on percussion. * History of pain with cold and sweets. * Radiographically, no internal or external resorption, no periapical or furcation radiolucency and no widening of the periodontal membrane space.

Exclusion criteria

* Teeth with pulp necrosis. * Presence of sinus tract. * Teeth with open apices. * Pregnant women. * History of intolerance of non- steroidal anti inflammatory drugs. * Tenderness to palpation of adjacent soft tissues

Design outcomes

Primary

MeasureTime frameDescription
Success rate of vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.one year1. Through post operative pain assessment using Visual analogue scale (0-3) scores as 0 represents no pain, 1= mild pain, 2= moderate pain and 3= sever pain. VAS scores marked at intervals of 2,6,24,48 and 72 hours. 2. Clinical success criteria: Clinical parameters indicating successful treatment include the following criteria: * Absence of pain except for the first 24 hours. * Normal soft tissue around the tooth ( no swelling, no sinus tract).
The Pulp vitalityone yearPulp vitality will be assessed through pulpal response to thermal and electrical pulp tests. at 3,6,12 months

Secondary

MeasureTime frameDescription
Radiographic successone yearUsing digital periapical radiograph at 3,6,12 months. Radiographic success criteria include: * No periapical pathosis. * No radicular resorption defects.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026